Anemia due to antineoplastic chemotherapy                                                                                                                                                                                                                        digital illustration

Anemia due to antineoplastic chemotherapy Save


ICD-10 code: D64.81

Disease category: D64.8: Other specified anemias

Anemia due to Antineoplastic Chemotherapy

Antineoplastic chemotherapy is a type of cancer treatment that uses powerful drugs to destroy cancer cells. Unfortunately, along with cancer cells, these drugs also affect healthy cells in the body, including red blood cells, leading to anemia. Anemia is a condition in which the body doesn't have enough healthy red blood cells to carry adequate oxygen to the tissues, leading to fatigue, weakness, and shortness of breath.

Here are some of the antineoplastic chemotherapy drugs that are known to cause anemia:

  1. Alkylating agents: These drugs damage the DNA of cancer cells, preventing them from dividing and multiplying. However, they also damage healthy cells, including bone marrow cells that produce red blood cells, leading to anemia.
  2. Antimetabolites: These drugs interfere with the metabolism of cancer cells, preventing them from growing and dividing. However, they also affect healthy cells, including red blood cells, leading to anemia.
  3. Platinum compounds: These drugs are used to treat several types of cancer, including lung, ovarian, and testicular cancer. However, they also affect healthy cells, including red blood cells, leading to anemia.

The severity of anemia due to antineoplastic chemotherapy depends on several factors, including the type of drug, the dosage, the duration of treatment, and the patient's overall health. Some patients may experience mild anemia, while others may develop severe anemia that requires blood transfusions.

Patients undergoing antineoplastic chemotherapy should be monitored closely for anemia, and their red blood cell counts should be checked regularly. If anemia is detected, the patient's doctor may adjust the dosage of the chemotherapy drugs or prescribe medications to stimulate the production of red blood cells.

In conclusion, anemia due to antineoplastic chemotherapy is a common side effect of cancer treatment that can lead to fatigue, weakness, and shortness of breath. Patients undergoing chemotherapy should be aware of this potential side effect and should be monitored closely for anemia.

Treatment of Anemia due to antineoplastic chemotherapy :

Treatment Options for Anemia due to Antineoplastic Chemotherapy

Antineoplastic chemotherapy is a common treatment for cancer. However, it can also cause anemia, a condition in which the blood lacks enough healthy red blood cells to carry oxygen to the body’s tissues. Anemia can cause fatigue, weakness, and shortness of breath, among other symptoms. Fortunately, there are several tr...

To see full information about treatment please Sign up or Log in